Cure Network Dolby Acceleration Partners LLC
San Francisco, United States · Founded 2021 · $3.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Total Funding
- $3.0M
- Last Round
- $3.0M GrantJan 2023
- Rounds
- 1
About
Cure Network Dolby Acceleration Partners (CNDAP) is a therapeutics company developing small-molecule Nav1.1 enhancers to treat Alzheimer's disease. The company was formed through a partnership between Cure Network Ventures (Gladstone Institutes) and Dolby Acceleration Partners to advance translational neuroscience research. Its lead program targets restoration of brain network gamma oscillations disrupted in early Alzheimer's pathology.
Summary
Cure Network Dolby Acceleration Partners LLC is a Biotech company based in San Francisco, United States, founded in 2021. It has raised $3.0M in total across 1 round, most recently a $3.0M Grant round in Jan 2023. Investors include National Institutes of Health.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cure-network-dolby-acceleration-partners-llc"><img src="https://indexed.vc/api/badge/company/cure-network-dolby-acceleration-partners-llc" alt="Cure Network Dolby Acceleration Partners LLC on Indexed.vc" width="260" height="76" /></a>